V
70
-6
CCI
31
-2
PG
53
-8
FRT
41
-4
ES
19
-9
BXP
50
-4
MPC
39
-5
NKE
40
-2
VRSK
73
-7
LB
45
11
C
62
-2
ADT
40
-3
MNST
55
-4
SYY
53
-3
TRV
55
-3
HRL
45
-2
ESS
59
-3
TGNA
53
-3
ITW
65
-5
AAL
45
-2
V
70
-6
CCI
31
-2
PG
53
-8
FRT
41
-4
ES
19
-9
BXP
50
-4
MPC
39
-5
NKE
40
-2
VRSK
73
-7
LB
45
11
C
62
-2
ADT
40
-3
MNST
55
-4
SYY
53
-3
TRV
55
-3
HRL
45
-2
ESS
59
-3
TGNA
53
-3
ITW
65
-5
AAL
45
-2
Financhill
Back

TransMedics Group Stock Predictions

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41

TMDX
TransMedics Group

Last Price:
72.23
Seasonality Move:
26.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

TransMedics Group Stock Forecast

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 51.1% based on the past 5 years of stock performance.
  • TransMedics Group has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is TransMedics Group Stock Undervalued?
    The current TransMedics Group [TMDX] share price is $71.44. The Score for TMDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TMDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will TransMedics Group Stock Go Up Next Year?

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 51.1% based on the past 5 years of stock performance.

TransMedics Group Stock Rating

Sell
41
TransMedics Group (TMDX) is a Sell

Is TransMedics Group overpriced?

  • TransMedics Group has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

TransMedics Group Stock Price History

Is TMDX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
transmedics.com

52-Week Data

52-Week High:
177.37
52-Week Low:
68.84

Prediction Charts

Market Cap:
2.4B
Price in USD:
71.44
Volume:
4.59M
Beta:
1.96

Technical Analysis

SMA50:
110.54
SMA100:
132.83
SMA200:
121.78
52-Wk Change:
-4.31%

Stock Predictions

  • Is TransMedics Group stock public?
    Yes, TransMedics Group is a publicly traded company.
  • What is the TransMedics Group stock quote today?
    The TransMedics Group stock price is 71.44 USD today.
  • How to buy TransMedics Group stock online?
    You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 92.94 92.77 98.88 92.30
Nov-14 92.62 88.36 92.84 87.71
Nov-15 88.93 80.48 88.93 80.06
Nov-18 78.21 80.93 81.31 76.21
Nov-19 80.81 82.92 83.24 80.02
Nov-20 80.89 77.20 81.09 75.61
Nov-21 77.20 79.34 80.89 76.60
Nov-22 76.00 76.04 76.87 72.68
Nov-25 77.99 78.58 78.99 76.28
Nov-26 78.19 80.61 81.22 77.69
Nov-27 81.55 87.11 87.57 81.48
Nov-29 87.47 86.71 89.38 86.51
Dec-2 87.02 85.14 87.02 84.00
Dec-3 77.08 71.44 78.71 71.25

TransMedics Group Earnings

TransMedics Group Earnings Report: Per Share TransMedics Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

TransMedics Group Forecast Revenue Growth

TransMedics Group Stock Analysis: Historical quarterly revenues per share for TransMedics Group and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $0.56 per share.

* TransMedics Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.